Related Experiment Video
Updated: Jan 31, 2026

Describing a Transcription Factor Dependent Regulation of the MicroRNA Transcriptome
Published on: June 15, 2016
The intracellular NADH level regulates atrophic nonunion pathogenesis through the CtBP2-p300-Runx2 transcriptional
Wentao Zhang1,2, Ning Duan2, Qian Zhang3
1Department of Orthopedics, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710005, Shaanxi, China.
Abstract:
Atrophic nonunion, a complicated failure of fracture healing, is still obscure regarding its molecular pathological mechanisms. Carboxyl-terminal binding proteins (CtBPs), an NADH-sensitive transcriptional corepressor family, are involved in many diseases, such as cancer and inflammation. Here, we found that CtBP2, but not CtBP1, was significantly overexpressed in atrophic nonunion tissues compared to healthy controls. Using a mass spectrometry assay, we found that CtBP2 can form a complex with histone acetyltransferase p300 and transcription factor Runx2. The lower NADH level in atrophic nonunion tissues disrupted CtBP2 dimerization and enhanced the blockage of the accessibility of the p300-Runx2 complex to the promoters of a series of bone-related target genes, such as OSC, ALPL, COL1A1, IBSP, SPP1 and MMP13. The expression of these genes can be reversed by a forced increase in NADH with CoCl2 treatment. In conclusion, our study revealed that NADH levels determine the expression of bone formation and development of related genes through affecting the dissociation or binding of CtBP2 to the p300-Runx2 complex. These results represent a conserved mechanism, by which CtBP2 serves as a NADH-dependent repressor of the p300-Runx2 transcriptional complex and thus affects bone formation.
Insights
Carboxyl-terminal binding protein 2 (CtBP2) is overexpressed in atrophic nonunion, hindering bone healing. Lower NADH levels disrupt CtBP2 binding to p300-Runx2, blocking bone-related gene expression.
Area of Science:
- Molecular Biology
- Biochemistry
- Orthopedics
Background:
- Atrophic nonunion is a complex fracture healing failure with unclear molecular mechanisms.
- Carboxyl-terminal binding proteins (CtBPs) are NADH-sensitive transcriptional corepressors implicated in various diseases.
Purpose of the Study:
- To investigate the role of CtBP2 in the molecular pathology of atrophic nonunion.
- To elucidate the mechanism by which CtBP2 influences bone-related gene expression in nonunion.
Main Methods:
- Mass spectrometry to identify protein complexes involving CtBP2.
- Analysis of CtBP2 and NADH levels in atrophic nonunion tissues.
- Investigating the effect of NADH levels on gene expression in vitro.
Main Results:
- CtBP2, not CtBP1, is significantly overexpressed in atrophic nonunion tissues.
- CtBP2 forms a complex with p300 and Runx2.
- Reduced NADH levels in nonunion disrupt CtBP2 dimerization, impairing p300-Runx2 access to bone-related gene promoters (e.g., OSC, ALPL, COL1A1).
- Restoring NADH levels with CoCl2 reversed the downregulation of these genes.
Conclusions:
- CtBP2 acts as a NADH-dependent repressor of the p300-Runx2 transcriptional complex.
- NADH levels critically regulate CtBP2 binding to p300-Runx2, thereby controlling the expression of genes essential for bone formation and development.
- This mechanism provides new insights into atrophic nonunion pathogenesis and potential therapeutic targets.
Related Concept Videos
Master Transcription Regulators
Master Transcription Regulators
Cooperative Binding of Transcription Regulators
Cooperative Binding of Transcription Regulators
Transcriptional Regulation: Riboswitches
Transcription Factors

